Science news articles about 'cml patients'Activation of LYN kinase is associated with imatinib-resistance in CML patients
... will surveying a larger patient sample to determine how frequently this type of resistance develops in CML patients.
"The work of [Donato and colleagues] takes us outside of the realm of thoroughly ... Arsenic-based therapy shown to help eradicate leukemia-initiating cells
... imatinib (Gleevec), a tyrosine kinase inhibitor.
“Gleevec does dramatically improve prognosis of CML patients,” notes Pandolfi. “But, unfortunately, Gleevec is not curative in most cases. Because it ... Combination of 2 novel anti-cancer agents may help fight CML resistant to current therapy
... Gleevec, is a highly effective anti-cancer agent that has revolutionized the course of therapy for patients with CML. It works by inhibiting the activity of a mutant protein, known as Bcr/Abl, which ... Combining math and medicine to treat leukemia
... -timed vaccine for chronic myelogenous leukemia (CML). The model takes into account the natural anti- ... Kim uses data collected over four years from CML patients during imatinib therapy.
"Our results ... A potential new way to make a good anti-leukemia drug even better
... leukemia cells in the past, is highly expressed in CML stem cells. When Zhou and colleagues blocked ... 1 in cancer cells from imatinib-resistant CML patients, they restored the ability of the drug to kill ... Microenvironment a main driver of aggressive multi-lineage leukemia disease type
... for the study, will allow testing of novel therapeutic strategies for MLL patients. They will also yield information that may be directly translatable into clinical interventions."
Leukemia is the ... Combining mathematics and medicine to treat leukaemia
... of an optimally-timed vaccine for chronic myelogenous leukaemia (CML). The model takes into account the natural anti-leukaemia response in patients that are treated with the drug imatinib...
Return to e! Science News homepage for the latest science news
Activation of LYN kinase is associated with imatinib-resistance in CML patients
... will surveying a larger patient sample to determine how frequently this type of resistance develops in CML patients. "The work of [Donato and colleagues] takes us outside of the realm of thoroughly ...Arsenic-based therapy shown to help eradicate leukemia-initiating cells
... imatinib (Gleevec), a tyrosine kinase inhibitor. “Gleevec does dramatically improve prognosis of CML patients,” notes Pandolfi. “But, unfortunately, Gleevec is not curative in most cases. Because it ...Combination of 2 novel anti-cancer agents may help fight CML resistant to current therapy
... Gleevec, is a highly effective anti-cancer agent that has revolutionized the course of therapy for patients with CML. It works by inhibiting the activity of a mutant protein, known as Bcr/Abl, which ...Combining math and medicine to treat leukemia
... -timed vaccine for chronic myelogenous leukemia (CML). The model takes into account the natural anti- ... Kim uses data collected over four years from CML patients during imatinib therapy. "Our results ...A potential new way to make a good anti-leukemia drug even better
... leukemia cells in the past, is highly expressed in CML stem cells. When Zhou and colleagues blocked ... 1 in cancer cells from imatinib-resistant CML patients, they restored the ability of the drug to kill ...Microenvironment a main driver of aggressive multi-lineage leukemia disease type
... for the study, will allow testing of novel therapeutic strategies for MLL patients. They will also yield information that may be directly translatable into clinical interventions." Leukemia is the ...Combining mathematics and medicine to treat leukaemia
... of an optimally-timed vaccine for chronic myelogenous leukaemia (CML). The model takes into account the natural anti-leukaemia response in patients that are treated with the drug imatinib...